Does apolipoprotein E genotype modify the clinical expression of ALS?

Background:  The presence of the apolipoprotein E (ApoE) 4 genotype is associated with an earlier age of onset for Alzheimer’s disease (AD) and several other neurodegenerative disorders. The objective of this study was to investigate the effect of ApoE genotypes on the clinical course of amyotrophic lateral sclerosis (ALS).

[1]  M. York,et al.  ALS disease onset may occur later in patients with pre‐morbid diabetes mellitus , 2010, European journal of neurology.

[2]  M. Freedman,et al.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[3]  K. Blennow,et al.  Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis , 2008, Journal of the Neurological Sciences.

[4]  J. Brandt,et al.  APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease , 2008, Neurology.

[5]  V. Meininger,et al.  Dyslipidemia is a protective factor in amyotrophic lateral sclerosis , 2008, Neurology.

[6]  B. Parmenter,et al.  Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms , 2007, Multiple sclerosis.

[7]  J. Vilkki,et al.  ApoE genotype and cognition after subarachnoid haemorrhage: a longitudinal study , 2006, Acta neurologica Scandinavica.

[8]  D. Perani,et al.  Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration , 2006, BMC neurology.

[9]  M. Poca,et al.  Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  D. Neary,et al.  The apolipoprotein E ε4 allele selectively increases the risk of frontotemporal lobar degeneration in males , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[11]  Robert H. Brown,et al.  Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS) , 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[12]  J. Haines,et al.  Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis , 2004, Neurogenetics.

[13]  J. Haines,et al.  Apolipoprotein E controls the risk and age at onset of Parkinson disease , 2004, Neurology.

[14]  D. Mann,et al.  Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer’s disease , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  M. Strong,et al.  High Threshold for Induction of the Stress Response in Motor Neurons Is Associated with Failure to Activate HSF1 , 2003, The Journal of Neuroscience.

[16]  T. Bird,et al.  Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. , 2002, Archives of neurology.

[17]  B. Dubois,et al.  Apolipoprotein E gene in frontotemporal dementia: an association study and meta-analysis , 2002, European Journal of Human Genetics.

[18]  V. Meininger,et al.  APOE: A potential marker of disease progression in ALS , 2002, Neurology.

[19]  Berrit C Stroehla,et al.  Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. , 2002, American journal of epidemiology.

[20]  C. Duijn,et al.  Influence of the prion protein and the apolipoprotein E genotype on the Creutzfeldt–Jakob Disease phenotype , 2001, Neuroscience Letters.

[21]  V. Drory,et al.  Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis , 2001, Journal of the Neurological Sciences.

[22]  R. Bedlack,et al.  Apolipoprotein E and neuromuscular disease: a critical review of the literature. , 2000, Archives of neurology.

[23]  C. Madl,et al.  The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. , 2000, Brain : a journal of neurology.

[24]  T. Tombaugh,et al.  Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. , 1999, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[25]  W. März,et al.  Apolipoprotein E Isoforms Increase Intracellular Ca2+ Differentially Through a ω‐Agatoxin IVa‐Sensitive Ca2+‐Channel , 1998, Brain pathology.

[26]  D. Michaelson,et al.  Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury , 1997, Neuroscience.

[27]  D. Michaelson,et al.  Reduced Levels of Antioxidants in Brains of Apolipoprotein E-Deficient Mice Following Closed Head Injury , 1997, Pharmacology Biochemistry and Behavior.

[28]  A. Malafosse,et al.  Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: evidence for a major influence on the clinical presentation and prognosis , 1996, Journal of the Neurological Sciences.

[29]  Robert H. Brown,et al.  Apolipoprotein E ϵ4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis , 1995 .

[30]  B. Brooks,et al.  El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.

[31]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[32]  M. Sliwinski,et al.  Development and validation of a model for estimating premorbid verbal intelligence in the elderly. , 1991, Journal of clinical and experimental neuropsychology.

[33]  E. Boerwinkle,et al.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. , 1991, American journal of human genetics.

[34]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[35]  G. Smith,et al.  A rating scale for amyotrophic lateral sclerosis: Description and preliminary experience , 1987, Annals of neurology.

[36]  C. Golden,et al.  Identification of brain disorders by the Stroop Color and Word Test. , 1976, Journal of clinical psychology.

[37]  N. G. Gordon.  The Trail Making Test in neuropsychological diagnosis. , 1972, Journal of clinical psychology.

[38]  V. Drory,et al.  Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. , 2001, Journal of the neurological sciences.

[39]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[40]  B. Hyman,et al.  Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. , 1995, Annals of neurology.